Systematic identification of pharmacogenomics information from clinical trials

Journal of Biomedical Informatics

Volumn 45, Issue 5, 2012, Pages 870-878

  Li, Jiao ^a   Lu, Zhiyong ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Clinical outcome; Clinical trial; Pharmacogenomics; Text mining

Indexed keywords

CANDIDATE GENES; CLINICAL OUTCOME; CLINICAL TRIAL; CROSSLINKS; FACTUAL KNOWLEDGE; HIGH-THROUGHPUT; KNOWLEDGE BASIS; MUTANT ALLELES; PHARMACOGENOMICS; RECENT PROGRESS; SYSTEMATIC IDENTIFICATION; TEXT MINING;

DATA MINING; GENES; MEDICAL APPLICATIONS;

EXPERIMENTS;

CAPECITABINE; CEFIXIME; CELECOXIB; CHLOROQUINE; ERLOTINIB; FLUOROURACIL; GEFITINIB; GLUCURONOSYLTRANSFERASE 1A1; IRINOTECAN; LEVOLEUCOVORIN; PACLITAXEL; TEMOZOLOMIDE;

ACCURACY; ADVANCED CANCER; ARTICLE; BILE DUCT CANCER; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; DATA MINING; DIGESTIVE SYSTEM CANCER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEAD AND NECK CANCER; HUMAN; INFORMATION PROCESSING; KNOWLEDGE; LUNG CANCER; MALARIA; MEDICAL INFORMATION; NEUROBLASTOMA; OVARY CANCER; PANCREAS CANCER; PHARMACOGENOMICS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PUBLICATION; REFERENCE DATABASE; STOMACH CANCER;

CLINICAL TRIALS AS TOPIC; DATA MINING; DATABASES, FACTUAL; GENOMICS; HUMANS; KNOWLEDGE BASES; PHARMACOGENETICS; PUBMED; TREATMENT OUTCOME;

EID: 84865961913     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2012.04.005     Document Type: Article

References (45)

1. Evans W.E., Relling M.V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999, 286(5439):487-491.
2. Penny M.A., McHale D. Pharmacogenomics and the drug discovery pipeline: when should it be implemented?. Am J Pharmacogenomics 2005, 5(1):53-62.
3. Klein T.E., Chang J.T., Cho M.K., Easton K.L., Fergerson R., Hewett M., et al. Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics research network and knowledge base. Pharmacogenomics J 2001, 1(3):167-170.
4. Thorn C.F., Klein T.E., Altman R.B. Pharmacogenomics and bioinformatics: PharmGKB. Pharmacogenomics 2010, 11(4):501-505.
5. Altman R.B., Flockhart D.A., Sherry S.T., Oliver D.E., Rubin D.L., Klein T.E. Indexing pharmacogenetic knowledge on the World Wide Web. Pharmacogenetics 2003, 13(1):3-5.
6. Garten Y., Coulet A., Altman R.B. Recent progress in automatically extracting information from the pharmacogenomic literature. Pharmacogenomics 2010, 11(10):1467-1489.
7. Chan A.W., Hrobjartsson A., Haahr M.T., Gotzsche P.C., Altman D.G. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004, 291(20):2457-2465.
8. Zarin D.A., Tse T. Medicine. Moving toward transparency of clinical trials. Science 2008, 319(5868):1340-1342.
9. The Food and Drug Administration Modernization Act of 1997. Pub. L. No. 105-115, 113; 1997.
10. ClinicalTrials.gov. http://clinicaltrials.gov/.
11. Hurdle JF, Botkin J, Rindflesch TC. Leveraging semantic knowledge in IRB databases to improve translation science. AMIA Annu Symp Proc; 2007. p. 349-53.
12. Rennie D. Trial registration: a great idea switches from ignored to irresistible. JAMA 2004, 292(11):1359-1362.
13. Xu R., Garten Y., Supekar K.S., Das A.K., Altman R.B., Garber A.M. Extracting subject demographic information from abstracts of randomized clinical trial reports. Stud Health Technol Inform 2007, 129(Pt 1):550-554.
14. Xu R, Supekar K, Huang Y, Das A, Garber A. Combining text classification and Hidden Markov Modeling techniques for categorizing sentences in randomized clinical trial abstracts. AMIA Annu Symp Proc; 2006. p. 824-8.
15. Orloff J., Douglas F., Pinheiro J., Levinson S., Branson M., Chaturvedi P., et al. The future of drug development: advancing clinical trial design. Nat Rev Drug Discov 2009, 8(12):949-957.
16. Kramer J.A., Sagartz J.E., Morris D.L. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates. Nat Rev Drug Discov 2007, 6(8):636-649.
17. Introduction to drug utilization research. Oslo, Norway: World Health Organization; 2003. p. 8.
18. ClinicalTrials.gov identifier to be added to MEDLINE®/PubMed® data. http://www.nlm.nih.gov/pubs/techbull/mj05/mj05_ct.html.
19. Tsai M.H., Lin K.M., Hsiao M.C., Shen W.W., Lu M.L., Tang H.S., et al. Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response. Pharmacogenomics 2010, 11(4):537-546.
20. Krajinovic M., Costea I., Chiasson S. Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia. Lancet 2002, 359(9311):1033-1034.
21. Jensen L.J., Saric J., Bork P. Literature mining for the biologist: from information retrieval to biological discovery. Nat Rev Genet 2006, 7(2):119-129.
22. Chang J.T., Schutze H., Altman R.B. GAPSCORE: finding gene and protein names one word at a time. Bioinformatics 2004, 20(2):216-225.
23. Caporaso J.G., Baumgartner W.A., Randolph D.A., Cohen K.B., Hunter L. MutationFinder: a high-performance system for extracting point mutation mentions from text. Bioinformatics 2007, 23(14):1862-1865.
24. Garten Y., Altman R.B. Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text. BMC Bioinformatics 2009, 10(Suppl. 2(S6)).
25. Ahlers CB, Fiszman M, Demner-Fushman D, Lang FM, Rindflesch TC. Extracting semantic predications from Medline citations for pharmacogenomics. Pac Symp Biocomput; 2007. p. 209-20.
26. Theobald M, Shah N, Shrager J. Extraction of conditional probabilities of the relationships between drugs, diseases, and genes from PubMed guided by relationships in PharmGKB. Summit on Translat Bioinforma; 2009. p. 124-8.
27. Coulet A., Shah N.H., Garten Y., Musen M., Altman R.B. Using text to build semantic networks for pharmacogenomics. J Biomed Inform 2010, 43(6):1009-1019.
28. Coulet A, Shah N, Hunter L, Barral C, Altman RB. Extraction of genotype-phenotype-drug relationships from text: from entity recognition to bioinformatics application. Pac Symp Biocomput, 2010. p. 485-7.
29. Cohen KB, Garten Y, Hahn U, Shah NH. Mining the pharmacogenomics literature - workshop introduction. Pac Symp Biocomput; 2011. p. 362-3.
30. Tu S.W., Peleg M., Carini S., Bobak M., Ross J., Rubin D., et al. A practical method for transforming free-text eligibility criteria into computable criteria. J Biomed Inform 2011, 44(2):239-250.
31. Weng C., Wu X., Luo Z., Boland M.R., Theodoratos D., Johnson S.B. EliXR: an approach to eligibility criteria extraction and representation. J Am Med Inform Assoc 2011.
32. Zarin D.A., Ide N.C., Tse T., Harlan W.R., West J.C., Lindberg D.A. Issues in the registration of clinical trials. JAMA 2007, 297(19):2112-2120.
33. Lindberg D.A., Humphreys B.L., McCray A.T. The unified medical language system. Methods Inform Med 1993, 32(4):281-291.
34. Ide N.C., Loane R.F., Demner-Fushman D. Essie: a concept-based search engine for structured biomedical text. J Am Med Inform Assoc 2007, 14(3):253-263.
35. Luo Z, Duffy R, Johnson S, Weng C. Corpus-based approach to creating a semantic lexicon for clinical research eligibility criteria from UMLS. In: AMIA summits on translational science proceedings. San Francisco, USA; 2010. p. 26-30.
36. Luo Z, Johnson SB, Weng C. Semi-automatically inducing semantic classes of clinical research eligibility criteria using UMLS and hierarchical clustering. In: AMIA annual symposium proceedings. Washington, DC, USA; 2010. p. 487-91.
37. Well known PGx gene-drug relationships. http://www.pharmgkb.org/resources/forScientificUsers/well_known_pairs_of_gene-drug_pgx_relationships.jsp.
38. PubMed®. http://www.ncbi.nlm.nih.gov/pubmed/.
39. Medical Subject Headings (MeSH®). http://www.nlm.nih.gov/mesh/.
40. How are pharmacogenomics articles annotated in PharmGKB? http://www.pharmgkb.org/resources/faqs.jsp#FAQs-annotatedPKPD.
41. Srinivasan P., Libbus B. Mining MEDLINE for implicit links between dietary substances and diseases. Bioinformatics 2004, 20(Suppl. 1):i290-i296.
42. Hristovski D., Peterlin B., Mitchell J.A., Humphrey S.M. Using literature-based discovery to identify disease candidate genes. Int J Med Inform 2005, 74(2-4):289-298.
43. Frijters R., van Vugt M., Smeets R., van Schaik R., de Vlieg J., Alkema W. Literature mining for the discovery of hidden connections between drugs, genes and diseases. PLoS Comput Biol 2010, 6(9).
44. De Marneffe MC, MacCartney B, Manning CD. Generating typed dependency parses from phrase structure parses. In: The international conference on language resources and evaluation. Genoa, Italy; 2006. p. 449-54.
45. Sherry S.T., Ward M.H., Kholodov M., Baker J., Phan L., Smigielski E.M., et al. DbSNP: the NCBI database of genetic variation. Nucl Acids Res 2001, 29(1):308-311.